These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
69 related items for PubMed ID: 2225417
1. Low-dose lovastatin safely lowers cholesterol after cardiac transplantation. Kobashigawa JA, Murphy FL, Stevenson LW, Moriguchi JD, Kawata N, Kamjoo P, Brownfield E, Wilmarth J, Leonard L, Chuck C. Circulation; 1990 Nov; 82(5 Suppl):IV281-3. PubMed ID: 2225417 [Abstract] [Full Text] [Related]
2. Safety and efficacy of low dose simvastatin in cardiac transplant recipients treated with cyclosporine. Vanhaecke J, Van Cleemput J, Van Lierde J, Daenen W, De Geest H. Transplantation; 1994 Jul 15; 58(1):42-5. PubMed ID: 8036706 [Abstract] [Full Text] [Related]
4. [A comparison of bezafibrate and lovastatin treatment at the usual doses in post-heart transplant hyperlipemia]. Zambrana García JL, López Miranda J, Anguita Sánchez M, Blanco Cerrada J, Vallés Belsúe F, Casares Mediavilla J, Muñoz Carvajal I, Jiménez Perepérez JA, Pérez Jiménez F. Rev Esp Cardiol; 1996 Dec 15; 49(12):892-8. PubMed ID: 9026840 [Abstract] [Full Text] [Related]
5. Hypercholesterolemia is common after pediatric heart transplantation: initial experience with pravastatin. Seipelt IM, Crawford SE, Rodgers S, Backer C, Mavroudis C, Seipelt RG, Pahl E. J Heart Lung Transplant; 2004 Mar 15; 23(3):317-22. PubMed ID: 15019641 [Abstract] [Full Text] [Related]
6. Lovastatin versus bezafibrate for hyperlipemia treatment after heart transplantation. Hidalgo L, Zambrana JL, Blanco-Molina A, López-Granados A, Concha M, Casares J, Jiménez-Pérez J, López-Miranda J, Pérez-Jiménez F. J Heart Lung Transplant; 1995 Mar 15; 14(3):461-7. PubMed ID: 7654731 [Abstract] [Full Text] [Related]
7. The determinants of elevated total plasma cholesterol levels in cardiac transplant recipients administered low dose cyclosporine for immunosuppression. Laufer G, Grablowitz V, Laczkovics A, Miholic J, Heinz G, Wollenek G, Schreiner W, Wolfram J, Wolner E. J Thorac Cardiovasc Surg; 1992 Aug 15; 104(2):241-7. PubMed ID: 1495285 [Abstract] [Full Text] [Related]
8. Effectiveness of low-dose lovastatin in lowering serum cholesterol. Experience with 56 patients. Bates MC, Warren SG, Grubb S, Chillag S. Arch Intern Med; 1990 Sep 15; 150(9):1947-50. PubMed ID: 2393325 [Abstract] [Full Text] [Related]
9. Comparative effects of lovastatin and niacin in primary hypercholesterolemia. A prospective trial. Illingworth DR, Stein EA, Mitchel YB, Dujovne CA, Frost PH, Knopp RH, Tun P, Zupkis RV, Greguski RA. Arch Intern Med; 1994 Jul 25; 154(14):1586-95. PubMed ID: 8031206 [Abstract] [Full Text] [Related]
10. [Effects of lovastatin in primary hypercholesterolemia]. Nakandakare ER, Garcia RC, Carré JM, Zerbinatti CV, Oliveira HC, Quintão EC. Arq Bras Cardiol; 1989 May 25; 52(5):291-5. PubMed ID: 2690785 [Abstract] [Full Text] [Related]
11. Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia. Almutairi F, Peterson TC, Molinari M, Walsh MJ, Alwayn I, Peltekian KM. Liver Transpl; 2009 May 25; 15(5):504-8. PubMed ID: 19399742 [Abstract] [Full Text] [Related]
12. Postmarketing analysis of lovastatin use in the VA Northern California System of Clinics: a retrospective, computer-based study. Swislocki AL, Lin K, Cogburn D, Fann KY, Khuu DT, Noth RH. Am J Manag Care; 1997 Oct 25; 3(10):1537-45. PubMed ID: 10178460 [Abstract] [Full Text] [Related]
13. Effects of lovastatin (20-80 mg daily) on lipoprotein fractions in patients with severe primary hypercholesterolemia. März W, Grützmacher P, Paul D, Siekmeier R, Schoeppe W, Gross W. Int J Clin Pharmacol Ther; 1994 Feb 25; 32(2):92-7. PubMed ID: 8004365 [Abstract] [Full Text] [Related]
14. Ezetimibe effectively lowers LDL-cholesterol in cardiac allograft recipients on stable statin therapy. Konstandin MH, Blessing E, Doesch A, Ammon K, Koch A, Wabnitz GH, Gleissner CA, Remppis A, Katus HA, Dengler TJ. Clin Transplant; 2008 Feb 25; 22(5):639-44. PubMed ID: 18492070 [Abstract] [Full Text] [Related]
15. Efficacy of low-dose cholesterol-lowering drug therapy in men with moderate hypercholesterolemia. Denke MA, Grundy SM. Arch Intern Med; 1995 Feb 27; 155(4):393-9. PubMed ID: 7848022 [Abstract] [Full Text] [Related]
16. Effect of lovastatin on serum lipids in patients with nonfamilial primary hypercholesterolemia. Itskovitz HD, Flamenbaum W, De Gaetano C, Pritchard KA, Stemerman MB. Clin Ther; 1989 Feb 27; 11(6):862-72. PubMed ID: 2611825 [Abstract] [Full Text] [Related]
17. Effect of combining viscous fibre with lovastatin on serum lipids in normal human subjects. Agrawal AR, Tandon M, Sharma PL. Int J Clin Pract; 2007 Nov 27; 61(11):1812-8. PubMed ID: 17935545 [Abstract] [Full Text] [Related]
18. [Hypercholesterolemia--a clinical problem in heart transplantation. A therapeutic trial with low-dose lovastatin]. Simonsen S, Gullestad L, Forfang K, Ihlen H, Nordal KP, Geiran O, Høstmark AT. Tidsskr Nor Laegeforen; 1995 Jan 30; 115(3):357-9. PubMed ID: 7855835 [Abstract] [Full Text] [Related]
19. Lovastatin therapy for hypercholesterolemia in cardiac transplant recipients. Kuo PC, Kirshenbaum JM, Gordon J, Laffel G, Young P, DiSesa VJ, Mudge GH, Vaughan DE. Am J Cardiol; 1989 Sep 15; 64(10):631-5. PubMed ID: 2675584 [Abstract] [Full Text] [Related]
20. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia. Saku K, Sasaki J, Arakawa K. Clin Ther; 1989 Sep 15; 11(2):247-57. PubMed ID: 2736571 [Abstract] [Full Text] [Related] Page: [Next] [New Search]